T he ideal schedule for cervical cancer screening in young women has been controversial, given the prevalent nature of human papilloma virus (HPV) infections and the fact that most HPVinduced lesions, even those of high grade, regress spontaneously in young women without intervention. 1, 2 Treatment of precancerous lesions, on the other hand, has been associated with adverse reproductive outcomes, an issue of most concern in young women of reproductive age. 3 The US Preventive Services Task Force (USPSTF) issued updated cervical cancer screening guidelines in 2012, changing the screening initiation age from 3 years after becoming sexually active to age 21 years because evidence suggested little to no benefit from screening women younger than age 21 years. [4] [5] [6] On the other hand, the USPSTF concluded with high certainty that the benefits of screening with cytology every 3 years substantially outweigh the harms for women aged 21e65 years.
Little is known about the cervical cancer screening initiation practices in the community and whether there are critical gaps with respect to adherence to current clinical guidelines. Despite an overall decline in cervical cancer incidence in women across all ages, the incidence rate has not declined among 24e25 year olds between 2000 (2.79 per 100,000) and 2013 (2.93 per 100,000). 7 Thus, it is important to understand cervical cancer screening initiation in young women and how woman-and provider-level factors affect the timing of screening initiation to improve the detection and treatment of preinvasive lesions and thus improve cervical cancer prevention. 8 Here we reported screening initiation behaviors in women reaching age 21 years between 2013 and 2015 and correlates of screening initiation in a large community-based practice.
Materials and Methods

Study setting
This study was conducted in Kaiser Permanente Southern California (KPSC), the largest integrated health care delivery system in Southern California, serving more than 4 million members (approximately 1% of the US population) who broadly represent the racial/ethnic and socioeconomic diversity in the broader geographic area. 9 KPSC provides comprehensive health care services to its members and, by nature of its prepaid managed care system, have comparable access to health care. Preventive care that includes cervical cancer screening are offered at no additional out-of-pocket costs. KPSC's cervical cancer screening guidelines generally follow the national guidelines. Guideline implementation efforts occur through a guideline committee, regional leaders, and KP best-practice web sites that inform practitioners about guideline changes. This study was approved by the KPSC Institutional Review Board.
Study design, inclusion, and exclusion
A retrospective cohort study design was used to examine patterns of screening initiation after the release of the 2012 USPSTF guidelines and associations between screening initiation and patient and provider characteristics. All female members who reached age 21 years (study baseline) anytime between Jan. 1, 2013, and Dec. 31, 2015, with no history of a Papanicolaou test or a total hysterectomy before age 21 years were eligible for inclusion. To enhance ascertainment of Papanicolaou and hysterectomy history, women were excluded if they were not continuously enrolled at KPSC for 4 years prior to age 21 years (ie, since age 17 years).
Follow-up
Follow-up started at age 21 years, which is the age when screening initiation is recommended by current clinical guidelines. 4 Women were observed to the initiation of Papanicolaou screening, a censoring event (hysterectomy, termination of KPSC membership, or death) or to Oct. 31, 2016, whichever came first.
Data collection
Information on the following women's characteristics were collected: race/ ethnicity, primary spoken language, census block education and income level, Medicaid enrollment, membership length, affiliated KPSC medical center, Papanicolaou testing during study follow-up, health care use 1 year prior to baseline, including number of office visits, emergency department (ED) visits, hospitalizations, and receipt of the influenza vaccination, gynecological information including a history of oral contraceptive use, pregnancy, sexually transmitted infections (specifically chlamydia, gonorrhea, syphilis, and herpes), and receipt of the HPV vaccination.
Information on women's primary care physician (PCP), including their sex and specialty, was also collected. All data were obtained from KPSC's electronic medical records that included clinical databases on diagnoses, procedures, pharmacy, utilization, immunization, laboratory tests, and providers.
Statistical analysis
The distributions of women's and providers' characteristics by Papanicolaou screening initiation status during study follow-up and a c 2 test for differences in characteristics were calculated. A cumulative incidence curve of screening initiation was constructed from life table methods using the Kaplan-Meier approach. 10 The screening initiation incidence rate was calculated per 100 person-years, the numerator representing the number of women initiating Papanicolaou screening during the observation period and the denominator representing the total person-time contributed by all women during follow-up. The corresponding 95% confidence intervals (CIs) were estimated based on Poisson regression. Because these calendar cohorts had different lengths of follow-up in the study, the 1 year incidence rate was also calculated separately for those who reached age 21 years in 2013, 2014, and 2015, respectively. In addition, the proportion initiating Papanicolaou screening was described among women with complete follow-up through the end of the study.
Associations between women's and providers' characteristics and screening initiation during study follow-up were evaluated using bivariate and multivariable Cox models that mutually adjusted for the previously described characteristics of interest. Categories/forms of each variable used for adjustment are shown in Table 1 . To address concerns of potential selection bias because of the 4 year prior membership requirement in the primary analysis, we completed a sensitivity analysis with all women who turned age 21 years between 2013 and 2015, regardless of their membership length prior to age 21 years.
To assess potential missed screening opportunities among those who did not initiate Papanicolaou screening during the study period, we also calculated the proportion of women with any outpatient encounters. All analyses were conducted using SAS software (version 9.3; SAS Institute Inc, Cary, NC).
Results
There were 79,316 KPSC female members who reached age 21 years between Jan. 1, 2013, and Dec. 31, 2015 . Of these, 47,687 (60%) had at least 4 years of previous continuous coverage. After excluding 4 women with a history of a total hysterectomy (0%) and 9426 who had a Papanicolaou test prior to baseline (20%), the final sample included 38,257 women with a total of 46,785 personyears of follow-up observed ( Figure 1 ). Of note, the proportion of women with Papanicolaou testing prior to age 21 years decreased from 30% in those who turned age 21 years in 2013 to 19% and 11% in those who turned age 21 years in 2014 and 2015, respectively.
Demographics and clinical characteristics of the study population are presented in Table 1 . A large proportion of the women were of Hispanic race/ ethnicity (45%). Most women had at least 1 outpatient visit in the 12 months prior to turning age 21 years (74%), and had a PCP in family practice (72%) who was female (70%). Most women had a history of receiving the HPV vaccine (76%), and half completed the 3 dose series (54%).
Of the 38,257 women included in the study, a total of 20,645 (54%) initiated Papanicolaou screening during the study period. The incidence rate of Papanicolaou screening initiation was 44 per 100 person-years (95% CI, 43e45). The 1 year screening initiation rate among women who reached age 21 years in 2013 was 51 per 100 person-years (CI, 49e52) and 57 per 100 person-years (CI, 56e59) in those who reached age 21 years in 2015.
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The mean and median follow-up time for all women was 1 year (mean, 1.2; SD, 0.96); and the mean and median time to screening among women who received a Papanicolaou test was less than 1 year, 0.8 (SD, 0.70) and 0.5 years, respectively. The cumulative incidence curve shows that approximately 40% of women initiated Papanicolaou screening within 1 year of turning age 21 years. The curve also suggested a steeper initial uptake of screening and a somewhat slowing trend 1 year after turning age 21 years ( Figure 2) . About 10% of the women did not have complete follow-up through the end of the study because of terminating membership (n ¼ 3757, 10%), death (n ¼ 11, 0%), or receiving a total hysterectomy (n ¼ 2, 0%). In a subanalysis of the women with complete follow-up through the end of October 2016, 58% initiated Papanicolaou screening during the follow-up period.
In the multivariable analysis, nonHispanic black and Hispanic women were slightly more likely to receive timely screening initiation compared with nonHispanic white women (hazard ratio [HR], 1.08; CI, 1.02e1.14; HR, 1.09; CI, 1.05e1.13, respectively), while Asian/ Pacific Islanders were less likely to have timely initiation (HR, 0.91; CI, 0.86e0.96) ( Table 2) , although the unadjusted absolute differences across all groups ranged between 4% and 6%.
Compared with native English speakers, having a primary language other than English was associated with lower screening initiation. Medicaid enrollees were less likely to have timely initiation compared with women not enrolled in Medicaid (ie, commercially insured) (HR, 0.90; CI, 0.83e0.97). Census block median household income was also marginally associated with screening initiation while census block education level was not.
Health care visits in the year prior to baseline, such as outpatient and ED visits, were associated with higher Papanicolaou screening initiation during the follow-up period (Table 2) . However, having an inpatient visit was associated with lower screening initiation (HR, 0.62; CI, 0.57e0.69).
PCP specialty was associated with screening initiation: those with a PCP in In the sensitivity analysis, although there were some differences in the magnitude of associations, the direction of associations, and thus interpretation, remained the same (data not shown).
Of the 17,612 women who did not initiate Papanicolaou screening by the end of the study follow-up, 11,423 (65%) had at least 1 outpatient visit during the observation period. In addition, the median number of outpatient visits during the observation period was 2.
Comment
Our findings suggest room for improving adherence to screening initiation recommendations among young women, especially among certain minority and disadvantaged subgroups, and improving equity in care delivery between male and female PCPs. Adherence to screening initiation guidelines (ie, initiating cervical cancer screening within 1 year after turning age 21 years) was approximately 40% as indicated by the 1 year cumulative incidence. The cumulative incidence curve suggested steady screening initiation over time, although only 75% initiated screening by age 24 years. Missed screening opportunities were observed in 65% of women who did not initiate screening but had an encounter with the health care system during the follow-up period. Variations in the cervical cancer screening initiation rate exist by woman-level factors because we found that women of Asian/Pacific Islander race/ethnicity, whose primary spoken language was not English, with public insurance and were recently hospitalized tend not to have timely screening initiation. On the other hand, a gynecological history such as pregnancy, oral contraceptive use, and sexually transmitted infections predicted timely screening initiation, likely because these women had early exposure to providers promoting gynecological health. In addition, a history of outpatient/ED visits and other preventive service use, such as flu and HPV vaccination, were associated with screening initiation (associations between screening initiation and HPV vaccination are consistent with our previous findings). 11 We also observed significant associations between timely screening initiation and women's PCP characteristics. Specifically, having a male PCP was strongly associated with lack of timely initiation.
Little has been reported about cervical cancer screening initiation in the literature, especially after the implementation of the 2012 guidelines. In our sample, 75% initiated screening by age 24 years. A study based on a national sample reported that 80% (2000e2010) among 22-24 year old women self-reported having a Papanicolaou test any time in the preceding 3 years. 12 Similarly, a study with a large US representative sample of women measuring Papanicolaou screening after receiving the HPV vaccine estimated screening rates at 79% (2006e2012). 13 Our initiation rate was slightly lower than these estimates, which may be due to variations in study methodology or 
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GYNECOLOGY Original Research population characteristics. For example, previous estimates represented any prior screening rate, instead of screening initiation among those previously unscreened. Our study was also based on medical record data, which avoided potential issues with self-report and differential survey participation. Our Southern California study population also consisted of more Hispanic women than the general US population. 14 However, based on the higher relative initiation among Hispanic women, compared with non-Hispanic white women, this may not explain the slightly lower rate we observed in our study.
Similarly, little has been reported on the correlates for variations in screening initiation. However, our findings are largely consistent with studies reporting on general cervical cancer screening adherence. Similar to other studies that examined the relative prevalence of screening in women of Asian/Pacific Islander race/ethnicity and other race/ ethnicity subgroups, we found lower relative cervical cancer screening initiation rates in Asian/Pacific Islanders. [15] [16] [17] That said, the magnitude of differences in screening initiation rates between racial/ethnic groups were relatively small (ie, <10%). It thus remains possible that these associations may still be explained by certain unmeasured clinical factors, rather than true differences between racial/ethnic groups. Asian Americans may seek cancer screening less often because of cultural factors. 16 Data on Asian subgroups in Northern California showed that Asian Indians, native Hawaiians, and Pacific Islanders have the lowest rates of screening, 18 although US data show Chinese women have the lowest Papanicolaou test uptake. 17 Despite lower screening initiation and adherence among women of Asian/Pacific Islander race/ethnicity, this subgroup has the lowest incidence of cervical cancer in the United States (6.1 per 100,000 women), while black and Hispanic women have the highest (9.9 and 9.8 per 100,000 women, respectively; 2009e2013). 19, 20 Although Hispanic women were more likely to be screened compared with white women in this study, other studies have found contrasting results, specifically of lower screening prevalence among native Mexican women. 17, 21 Thus, improving cervical cancer screening initiation in racial/ethnic subgroups of women may need to be culturally tailored.
Having a primary language other than English and having Medicaid insurance were associated with lower screening initiation. Populations with these characteristics are recognized as disadvantaged when it comes to accessing preventive care. 22 Limited English proficiency is typically associated with lower acculturation and limited health literacy, a barrier to accessing health information and understanding care associated with undergoing Papanicolaou tests. [23] [24] [25] Similarly, women with Medicaid insurance often represent a low-income group. A qualitative study that interviewed low-income women with access to care found that the primary drivers of cervical cancer screening nonadherence included lack of knowledge of resources, fear, competing obligations, and embarrassment. 25 Women with a PCP in family medicine had a higher rate of Papanicolaou screening initiation than women with a PCP in pediatrics, internal medicine, or another specialty. This observation may reflect different patterns of integrating Papanicolaou screening into clinical practice by different specialties, such as integrating obstetrics-gynecology specialists who may in effect be performing Papanicolaou screens in family practice settings. In addition, patient-provider gender concordance appeared to be an important factor in screening initiation, a finding consistent with a recent study on cancer screening based in a different health system 18 The magnitude of the association was relatively large (HR, 0.46; CI, 0.36e0.57), perhaps a reflection of young women's discomfort with having their first Papanicolaou test with a provider of the opposite sex or male providers' discomfort in offering first cervical cancer screenings to young women. A prior study also found that having a male PCP was associated with lower HPV vaccine initiation. 26 To this end, a study reported that female providers tend to have more favorable attitudes toward prevention than male providers. 27 It is also possible that the Cumulative incidence curve and CI band of screening initiation probability CI, confidence interval. Original Research GYNECOLOGY ajog.org practice of some physicians may be affected by studies suggesting that cervical cancer screening initiation can be safely delayed until age 25 years, 28, 29 despite the evidence being considered generally insufficient. Qualitative studies are needed to further understand physicians' attitude, barriers, and facilitators in initiating cervical cancer screening in young women. Consistent with other studies, accessing health services such as primary, acute, or preventive care were found to be positively associated with cervical cancer screening initiation and adherence, 18, 30, 31 indicators of health care engagement. In KPSC, delivery of preventive care is enhanced by proactive care encounters, an electronic medical records reminder system of preventive services due and seen by providers when a member makes a clinical visit. 32 However, inpatient visits in the 1 year prior to baseline were inversely associated with cervical cancer screening initiation, possibly because of young women attending to higherpriority health needs and consequently less attentive to their preventive care needs than their counterparts. 33 Outreach to women enrolled in KPSC who become newly eligible for Papanicolaou screening is performed regularly via an electronic e-mail system or mailing followed by a reminder call, a method shown to be effective in prompting women to get screened for cervical cancer. 34 However, it is argued that these strategies are more effective in women who are already engaged in their care. 35 Yet we found that 65% of women who did not initiate Papanicolaou screening indeed had outpatient visits during the follow-up period, indicating missed opportunities for screening. Thus, closing gaps for cervical cancer screening initiation may require additional multilevel interventions.
One limitation of this study is that results may not be generalizable to women in other health care settings, especially those who are uninsured. However, trends in the United States have moved toward a managed care system in many health care settings vs the opportunistic fee-for-service model. This study provides data on cervical cancer initiation in women reaching age 21 years in a large community-based health care practice. Interventions to support all young women to initiate screening as recommended are needed. Future qualitative studies can also provide better understanding of barriers and facilitators at both the provider's and women's levels. Nevertheless, strategies to address barriers related to health care providers, such as those experienced by male providers when getting young women to start Papanicolaou testing, may help close gaps in guideline adherence. n Original Research GYNECOLOGY ajog.org
